Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A girl with a rare skin condition improved after one month of treatment with acitretin.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

AMPK activation may reduce melanoma risk in red-haired individuals.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Axitinib treatment turned a man's grey hair back to black.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Omalizumab may cause hair loss.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Plerixafor may help restore skin pigmentation safely.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.